Sisram Medical pre-markets $200m HK float
Sisram Medical has begun sounding out investors for its $200m IPO in Hong Kong after receiving listing approval from the city’s stock exchange, said bankers on the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: